NorthWest Biotherapeutics Inc (NWBO)

[longusa]

The drug companies eat the 'rebate' (discount). This careful cost control that is common in just about every country other than the US is why most other developed economies, such as Germany and UK, spend approx. 10% of GDP on health care (and cover all citizens), while US is at 18%.

The good news for NW is that the DCVax is so cost efficient. One apheresis and manufacturing run generates the entire 10 dose treatment regime. This gives tremendous flexibility in pricing - NW can still make money even at low price levels.